Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Biogen Inc.

Market Cap 29.02B 25.3B 23.44B 21.94B 41.15B 2,738B 41.39B 278B 108B 1,348B 109B 107B 4,680B P/E 2026 *
31.7x
P/E 2027 * 16.5x
Enterprise Value 34.39B 29.99B 27.77B 26B 48.76B 3,245B 49.06B 329B 128B 1,597B 129B 126B 5,547B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.12x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week-1.73%
Current month+0.30%
1 month+3.75%
3 months+8.33%
6 months+12.46%
Current year+11.70%
1 week 193.2
Extreme 193.195
201.75
1 month 184.9
Extreme 184.9
203.45
Current year 160.36
Extreme 160.3645
205.97
1 year 121.05
Extreme 121.05
205.97
3 years 110.04
Extreme 110.035
293.52
5 years 110.04
Extreme 110.035
376.01
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
06-09Free

Director

1,505 0.0010%
06-09Free

Director

1,505 0.0010%
06-09Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-1.73%+54.74%-33.22% 29.02B
+0.33%-0.36%+19.66%-21.68% 62.05B
+0.20%-9.17%+58.54%+196.91% 54.52B
-3.92%+37.40%+37.40%+37.40% 41.55B
-1.19%+8.53%-52.43%-59.39% 39.06B
+3.50%+28.15%+146.95%-47.17% 25.38B
-0.78%-9.50%+43.47%+58.70% 19.62B
-4.27%-5.94%-7.73%+139.08% 16.89B
-0.05%+0.23%+61.48%+107.84% 15.89B
-1.66%-0.79%+58.81%+295.64% 12.98B
Average -0.94%+2.31%+42.09%+67.41% 31.7B
Weighted average by Cap. -0.77%+1.58%+36.91%+48.95%

Financials

2026 *2027 *
Net sales 10.05B 8.76B 8.12B 7.6B 14.25B 949B 14.34B 96.3B 37.32B 467B 37.73B 36.92B 1,621B 10.38B 9.05B 8.38B 7.85B 14.72B 980B 14.81B 99.45B 38.54B 482B 38.97B 38.13B 1,674B
Net income 1.18B 1.03B 951M 890M 1.67B 111B 1.68B 11.28B 4.37B 54.67B 4.42B 4.32B 190B 1.97B 1.72B 1.59B 1.49B 2.79B 186B 2.81B 18.86B 7.31B 91.43B 7.39B 7.23B 317B
Net Debt 5.37B 4.68B 4.34B 4.06B 7.62B 507B 7.66B 51.46B 19.94B 250B 20.17B 19.73B 866B 3.35B 2.92B 2.71B 2.53B 4.75B 316B 4.78B 32.09B 12.44B 156B 12.57B 12.3B 540B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
18/06/26 196.58 $ -1.05% 1,729,826
17/06/26 198.67 $ +1.56% 1,009,032
16/06/26 195.61 $ -1.53% 1,110,656
15/06/26 198.64 $ -0.70% 883,963
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
196.58USD
Average target price
220.25USD
Spread / Average Target
+12.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!